Aikium
PrivateLast Round
Pre Seed
Nov 15, 2024
Total Funding Raised
$1.2M
Company Overview
Aikium is a biotechnology company that develops protein therapeutics for neuro-inflammation and oncology. The company leverages breakthroughs in synthetic biology and deep learning to develop proprietary non-antibody scaffold proteins.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aikium Comps
Public and private peers based on sector, stage, and business model.
Aikium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Nov 15, 2024 |
Key People
Founding team and executive leadership
Aikium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3i Partners | Pre Seed |
| Bantam Group | Pre Seed |
| Civilization Ventures | Pre Seed |
| Fellows Fund | Pre Seed |
Aikium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aikium's valuation, stock price, and market status.
